BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 11826083)

  • 1. Modulation of somatodendritic dopamine release by endogenous H(2)O(2): susceptibility in substantia nigra but resistance in VTA.
    Chen BT; Avshalumov MV; Rice ME
    J Neurophysiol; 2002 Feb; 87(2):1155-8. PubMed ID: 11826083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of electrically evoked dopamine release and reuptake in substantia nigra, ventral tegmental area, and striatum.
    Cragg S; Rice ME; Greenfield SA
    J Neurophysiol; 1997 Feb; 77(2):863-73. PubMed ID: 9065855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synaptic regulation of somatodendritic dopamine release by glutamate and GABA differs between substantia nigra and ventral tegmental area.
    Chen BT; Rice ME
    J Neurochem; 2002 Apr; 81(1):158-69. PubMed ID: 12067228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of electrically evoked somatodendritic dopamine release in substantia nigra and ventral tegmental area in vitro.
    Rice ME; Cragg SJ; Greenfield SA
    J Neurophysiol; 1997 Feb; 77(2):853-62. PubMed ID: 9065854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential calcium dependence of axonal versus somatodendritic dopamine release, with characteristics of both in the ventral tegmental area.
    Chen BT; Patel JC; Moran KA; Rice ME
    Front Syst Neurosci; 2011; 5():39. PubMed ID: 21716634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Ca2+ dependence and time course of somatodendritic dopamine release: substantia nigra versus striatum.
    Chen BT; Rice ME
    J Neurosci; 2001 Oct; 21(19):7841-7. PubMed ID: 11567075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential autoreceptor control of somatodendritic and axon terminal dopamine release in substantia nigra, ventral tegmental area, and striatum.
    Cragg SJ; Greenfield SA
    J Neurosci; 1997 Aug; 17(15):5738-46. PubMed ID: 9221772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limited regulation of somatodendritic dopamine release by voltage-sensitive Ca channels contrasted with strong regulation of axonal dopamine release.
    Chen BT; Moran KA; Avshalumov MV; Rice ME
    J Neurochem; 2006 Feb; 96(3):645-55. PubMed ID: 16405515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential modulation by nicotine of substantia nigra versus ventral tegmental area dopamine neurons.
    Keath JR; Iacoviello MP; Barrett LE; Mansvelder HD; McGehee DS
    J Neurophysiol; 2007 Dec; 98(6):3388-96. PubMed ID: 17942622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of serotonin and dopamine release in substantia nigra and ventral tegmental area: region and species differences.
    Cragg SJ; Hawkey CR; Greenfield SA
    J Neurochem; 1997 Dec; 69(6):2378-86. PubMed ID: 9375669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noradrenergic Modulation of Dopamine Transmission Evoked by Electrical Stimulation of the Locus Coeruleus in the Rat Brain.
    Park JW; Bhimani RV; Park J
    ACS Chem Neurosci; 2017 Sep; 8(9):1913-1924. PubMed ID: 28594540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mobilization of calcium from intracellular stores facilitates somatodendritic dopamine release.
    Patel JC; Witkovsky P; Avshalumov MV; Rice ME
    J Neurosci; 2009 May; 29(20):6568-79. PubMed ID: 19458227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracerebroventricular administration of NMDA-R1 antisense oligodeoxynucleotide significantly alters the activity of ventral tegmental area dopamine neurons: an electrophysiological study.
    Tajiri K; Emori K; Murata M; Tanaka K; Suzuki M; Uehara T; Sumiyoshi T; Ashby CR; Kurachi M
    Synapse; 2001 Jun; 40(4):275-81. PubMed ID: 11309843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine-mediated volume transmission in midbrain is regulated by distinct extracellular geometry and uptake.
    Cragg SJ; Nicholson C; Kume-Kick J; Tao L; Rice ME
    J Neurophysiol; 2001 Apr; 85(4):1761-71. PubMed ID: 11287497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurochemical characterization of the release and uptake of dopamine in ventral tegmental area and serotonin in substantia nigra of the mouse.
    John CE; Budygin EA; Mateo Y; Jones SR
    J Neurochem; 2006 Jan; 96(1):267-82. PubMed ID: 16300629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. H(2)O(2) is a novel, endogenous modulator of synaptic dopamine release.
    Chen BT; Avshalumov MV; Rice ME
    J Neurophysiol; 2001 Jun; 85(6):2468-76. PubMed ID: 11387393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct monitoring of dopamine and 5-HT release in substantia nigra and ventral tegmental area in vitro.
    Rice ME; Richards CD; Nedergaard S; Hounsgaard J; Nicholson C; Greenfield SA
    Exp Brain Res; 1994; 100(3):395-406. PubMed ID: 7813678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. α2A adrenergic receptors highly expressed in mesoprefrontal dopamine neurons.
    Castelli MP; Spiga S; Perra A; Madeddu C; Mulas G; Ennas MG; Gessa GL
    Neuroscience; 2016 Sep; 332():130-9. PubMed ID: 27365174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ventral tegmental area revisited: is there an electrophysiological marker for dopaminergic neurons?
    Margolis EB; Lock H; Hjelmstad GO; Fields HL
    J Physiol; 2006 Dec; 577(Pt 3):907-24. PubMed ID: 16959856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The abused inhalant toluene increases dopamine release in the nucleus accumbens by directly stimulating ventral tegmental area neurons.
    Riegel AC; Zapata A; Shippenberg TS; French ED
    Neuropsychopharmacology; 2007 Jul; 32(7):1558-69. PubMed ID: 17213847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.